Taysha Gene Therapies Inc (TSHA) stock news · rev $9.8M
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
This TSHA news page leads with what Taysha Gene Therapies Inc filed — not a scraped headline mill.
No cached 8-K sentence for TSHA yet. We will not pad this page with generic market recap.
Latest reported TSHA revenue for 2025-12-31 was $9.8M. Net income was -$109.0M. Revenue was up 17.3% from 2024-12-31 to 2025-12-31. TSHA currently screens at market cap $640.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TSHA stock page; for the tape open the quote page.
TSHA stock news FAQ
What are TSHA's latest revenue and net income?
Latest cached Taysha Gene Therapies Inc (TSHA) revenue for Dec 31, 2025 was $9.8M. Net income was -$109.0M. Statements: https://lician.com/financials/tsha
How did TSHA revenue change from the prior cached period?
Cached Taysha Gene Therapies Inc (TSHA) revenue was up 17.3% from $8.3M (Dec 31, 2024) to $9.8M (Dec 31, 2025). Statements: https://lician.com/financials/tsha
What is TSHA's market cap?
Taysha Gene Therapies Inc (TSHA) market cap is $640.7M on the latest cached fundamentals snapshot.
What kind of company is TSHA?
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Where is TSHA stock news listed?
Cached stock news for Taysha Gene Therapies Inc (TSHA) is listed at https://lician.com/news/tsha. Filings: https://lician.com/sec/tsha
Not investment advice.